The novel treatment of this peptide represents a significant breakthrough in the management of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide372752.bloggin-ads.com/65179926/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment